参考文献:1.Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB et al (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354(9173):93–99CrossRef PubMed 2.Ehdaie B, Stukenborg GJ, Theodorescu D (2009) Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer. J Urol 182(4):1482–1487CrossRef PubMed 3.Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y et al (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3(5):1526–1533CrossRef PubMed PubMedCentral 4.Vamvakas S, Bahner U, Heidland A (1998) Cancer in end-stage renal disease: potential factors involved -editorial. Am J Nephrol 18(2):89–95CrossRef PubMed 5.Matas AJ, Simmons RL, Kjellstrand CM, Buselmeier TJ, Najarian JS (1975) Increased incidence of malignancy during chronic renal failure. Lancet 1(7912):883–886CrossRef PubMed 6.Wu CF, Pang ST, Shee JJ, Chang PL, Chuang CK, Chen CS et al (2010) Identification of genetic alterations in upper urinary tract urothelial carcinoma in end-stage renal disease patients. Genes Chromosomes Cancer 49(10):928–934CrossRef PubMed 7.Stopper H, Schupp N, Klassen A, Sebekova K, Heidland A (2005) Genomic damage in chronic renal failure–potential therapeutic interventions. J Ren Nutr 15(1):81–86CrossRef PubMed 8.Stewart JH, Buccianti G, Agodoa L, Gellert R, McCredie MR, Lowenfels AB et al (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14(1):197–207CrossRef PubMed 9.Malachi T, Zevin D, Gafter U, Chagnac A, Slor H, Levi J (1993) DNA repair and recovery of RNA synthesis in uremic patients. Kidney Int 44(2):385–389CrossRef PubMed 10.Yossepowitch O, Sagy I, Margel D, Baniel J (2012) Urothelial carcinoma of the bladder in patients on hemodialysis: clinical characteristics and oncological outcomes. J Urol 187(4):1215–1219CrossRef PubMed 11.Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST (2006) The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol 176(2):477–481CrossRef PubMed 12.Wu CF, Shee JJ, Ho DR, Chen WC, Chen CS (2004) Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma. J Urol 171(1):126–129CrossRef PubMed 13.Tseng SF, Chuang YC, Yang WC (2011) Long-term outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma. Int Urol Nephrol 43(4):1067–1071CrossRef PubMed 14.Kang CH, Chen CH, Chiang PH (2010) Primary urothelial carcinoma of the upper urinary tract in dialysis patients with 5-year follow-up. Jpn J Clin Oncol 40(3):241–246CrossRef PubMed 15.Satoh S, Tsuchiya N, Habuchi T, Ishiyama T, Seimo K, Kato T (2005) Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis. J Urol 174(5):1749–1753CrossRef PubMed 16.Veltman GA, Bosch FH, van der Plas-Cats MB, van Leusen R (1991) Urine cytology as a screening method for transitional-cell carcinoma in dialysis patients with analgesic nephropathy. Nephrol Dial Transplant 6(5):346–348CrossRef PubMed 17.Hadatsuki H, Sasagawa I, Suzuki H, Yaguchi H, Mutoh A, Kubota Y et al (1998) Bladder cancer in a patient on long-term haemodialysis. Int Urol Nephrol 30(5):565–568CrossRef PubMed 18.Lin MY, Kuo MC, Hung CC, Wu WJ, Chen LT, Yu ML et al (2015) Association of dialysis with the risks of cancers. Plos One 10(4):e0122856CrossRef PubMed PubMedCentral
1. Department of Urology, Kidney Center, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan
刊物类别:Medicine
刊物主题:Medicine & Public Health Nephrology Urology and Andrology
出版者:Springer Netherlands
ISSN:1573-2584
文摘
Purpose To clarify the background, clinical symptoms, pathological characteristics, and duration of survival in patients with bladder cancer on hemodialysis and to examine the appropriate treatment strategies.